Expression of FOXP1 and p53 in Reactive Lymphoid Lesion and B-cell Non-Hodgkin Lymphoma, Large Cell Type

Authors

  • Ita Ellyana1,2,3, Nila Kurniasari4,5,6

DOI:

https://doi.org/10.37506/ijfmt.v15i1.13575

Keywords:

reactive lymphoid hyperplasia, B-cell Non-Hodgkin lymphoma, FOXP1, p53

Abstract

Lymphoproliferative lesions that have morphology between benign and malignant are difficult to diagnose
even with immunohistochemical and clonality testing. The correct diagnosis is necessary for the prompt
treatment. These lesions can also serve as instructive models of lymphomagenesis. FOXP1 plays an important
role in B-cell development, has a potential oncogene in B-cell Non-Hodgkin lymphoma, and p53 protein
has a crucial role in the regulation of cell cycle, DNA repair, apoptosis, and senescence tumor suppression
activity. In this study, we analyze the role of FOXP1 and p53 expression in reactive lymphoid hyperplasia
and B-cell Non-Hodgkin lymphoma, large cell type. 68 paraffin blocks samples from patients diagnosed
as reactive lymphoid hyperplasia and B-cell Non-Hodgkin lymphoma, large cell type was sectioned and
stained with immunohistochemistry for FOXP1 and p53, and the percentage of nuclear cells showing
positive staining were evaluated. Expression of FOXP1 and p53 in B-cell Non-Hodgkin lymphoma, large
cell type is higher than in reactive lymphoid hyperplasia with p=0.001 and cutoff point 45%(CI=95%) for
FOXP1 and p=0.001 and cutoff point 7.5%(CI=95%) for p53. There is a significant correlation between the
expression of FOXP1 and p53 in reactive lymphoid hyperplasia and B-cell Non-Hodgkin lymphoma, large
cell type (p=0.001). Our findings suggest that high expression of FOXP1 and p53 in B-cell Non-Hodgkin
lymphoma may demonstrate the role of FOXP1 and p53 in lymphomagenesis and these markers may help
to distinguish benign and malignant lymphoproliferative lesions.

Author Biography

Ita Ellyana1,2,3, Nila Kurniasari4,5,6

1
Resident, Department of Anatomical Pathology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia,
2Resident, Universitas Airlangga Hospital, Universitas Airlangga, Surabaya, Indonesia, 3
Resident, Dr. Soetomo
General Academic Hospital, Surabaya, Indonesia, 4Lecturer, Department of Anatomical Pathology, Faculty of
Medicine, Universitas Airlangga, Surabaya, Indonesia, 5
Lecturer, Universitas Airlangga Hospital, Universitas
Airlangga, Surabaya, Indonesia, 6Lecturer, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.

Published

2020-12-31

How to Cite

Ita Ellyana1,2,3, Nila Kurniasari4,5,6. (2020). Expression of FOXP1 and p53 in Reactive Lymphoid Lesion and B-cell Non-Hodgkin Lymphoma, Large Cell Type . Indian Journal of Forensic Medicine & Toxicology, 15(1), 1161-1167. https://doi.org/10.37506/ijfmt.v15i1.13575

Issue

Vol. 15 No. 1 (2021): Indian Journal of Forensic Medicine & Toxicology

Section

Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details

https://creativecommons.org/licenses/

CC BY

This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.

  1. The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
  1. The journal allows the author(s) to hold the copyright without restrictions.
  1. The journal allows the author(s) to retain publishing rights without restrictions